Mpox and Pregnancy: Emerging concerns and Limited Data

Mpox outbreaks have raised global health concerns, with a particularly important impact in the Democratic Republic of Congo (DR Congo). this region experiences ongoing endemic activity of mpox clade 1. While the risk of mother-to-child transmission (vertical transmission) is established, information regarding the effects of mpox clade I infection during pregnancy remains scarce. Current understanding is largely based on limited case studies,highlighting a critical gap in medical knowledge.

The limited data presents challenges for healthcare providers managing pregnant individuals in areas where mpox is present. it’s challenging to fully assess the potential risks to both mother and developing fetus. Researchers are working to gather more complete information to inform clinical guidelines and improve patient care. Understanding the specific impacts of clade 1 mpox during pregnancy is crucial, as it differs from the clade 2 variant that drove recent global outbreaks.

Vertical transmission of mpox, meaning the passage of the virus from mother to baby during pregnancy, childbirth, or breastfeeding, is a known possibility. However, the rate of transmission and the severity of illness in infants exposed in utero are not yet well-defined. More research is needed to determine if infection during specific stages of pregnancy poses a greater risk.

Currently, healthcare professionals must rely on a cautious approach, prioritizing preventative measures and close monitoring of pregnant individuals who may have been exposed to mpox. This includes vaccination where available and appropriate, and prompt diagnosis and treatment of any suspected cases. Further examination is essential to provide evidence-based recommendations for managing mpox during pregnancy and minimizing potential adverse outcomes.

The lack of robust data underscores the urgent need for expanded surveillance and research efforts focused on mpox and pregnancy, particularly in endemic regions like the DR Congo.This will help to better understand the disease’s impact and develop effective strategies to protect both maternal and infant health.